Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
0.00%
)
Bitcoin
79,054.09
(
-0.01%
)
News Focus
News Focus
Post# of 257578
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: zebra4o1 post# 34007

Wednesday, 09/13/2006 11:18:31 PM

Wednesday, September 13, 2006 11:18:31 PM

Post# of 257578
ARNA – If they can get phase-3 done for only $125M, I’ll be impressed—that comes to just $20K per patient, which is not a lot for trials of these durations.

p.s. I have a new example of Zebra’s Law: VRX’s Viramune for program for HCV (#msg-13246012). If this program were owned by a Big Pharma, I think it would now be in the trash can.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today